End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
8.19
CNY
|
+1.61%
|
|
-3.42%
|
-32.87%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,976
|
2,690
|
2,887
|
4,118
|
2,217
|
3,375
|
Enterprise Value (EV)
1 |
3,282
|
2,863
|
3,339
|
4,484
|
2,754
|
3,555
|
P/E ratio
|
51.4
x
|
88.4
x
|
-3.88
x
|
295
x
|
-4.78
x
|
-5.1
x
|
Yield
|
0.71%
|
0.39%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.35
x
|
1.46
x
|
1.75
x
|
1.24
x
|
0.56
x
|
1.11
x
|
EV / Revenue
|
1.49
x
|
1.56
x
|
2.03
x
|
1.35
x
|
0.69
x
|
1.17
x
|
EV / EBITDA
|
22.1
x
|
24.6
x
|
-7.47
x
|
37.4
x
|
-13.2
x
|
-15.8
x
|
EV / FCF
|
-15.2
x
|
21.5
x
|
-16.4
x
|
25
x
|
-32.2
x
|
155
x
|
FCF Yield
|
-6.56%
|
4.66%
|
-6.1%
|
4%
|
-3.1%
|
0.64%
|
Price to Book
|
2.07
x
|
1.86
x
|
4.16
x
|
5.84
x
|
9.55
x
|
12.8
x
|
Nbr of stocks (in thousands)
|
212,145
|
212,145
|
212,145
|
212,145
|
213,574
|
276,630
|
Reference price
2 |
14.03
|
12.68
|
13.61
|
19.41
|
10.38
|
12.20
|
Announcement Date
|
4/25/19
|
4/23/20
|
4/26/21
|
4/27/22
|
4/26/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,202
|
1,840
|
1,646
|
3,331
|
3,962
|
3,029
|
EBITDA
1 |
148.2
|
116.4
|
-447
|
119.8
|
-209.1
|
-225.2
|
EBIT
1 |
107.1
|
67.94
|
-498.7
|
64
|
-265.3
|
-277.9
|
Operating Margin
|
4.86%
|
3.69%
|
-30.29%
|
1.92%
|
-6.7%
|
-9.18%
|
Earnings before Tax (EBT)
1 |
56.12
|
24.06
|
-780.3
|
6.016
|
-455.7
|
-419
|
Net income
1 |
57.91
|
30.43
|
-745
|
13.98
|
-460.4
|
-519.1
|
Net margin
|
2.63%
|
1.65%
|
-45.25%
|
0.42%
|
-11.62%
|
-17.14%
|
EPS
2 |
0.2730
|
0.1435
|
-3.512
|
0.0659
|
-2.170
|
-2.390
|
Free Cash Flow
1 |
-215.5
|
133.4
|
-203.6
|
179.3
|
-85.4
|
22.9
|
FCF margin
|
-9.78%
|
7.25%
|
-12.37%
|
5.38%
|
-2.16%
|
0.76%
|
FCF Conversion (EBITDA)
|
-
|
114.59%
|
-
|
149.65%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
438.43%
|
-
|
1,281.87%
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
0.0500
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/19
|
4/23/20
|
4/26/21
|
4/27/22
|
4/26/23
|
4/25/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
15.76
|
Net margin
|
-
|
EPS
2 |
0.0743
|
Dividend per Share
|
-
|
Announcement Date
|
4/27/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
306
|
173
|
452
|
366
|
537
|
180
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.062
x
|
1.487
x
|
-1.011
x
|
3.056
x
|
-2.567
x
|
-0.8001
x
|
Free Cash Flow
1 |
-215
|
133
|
-204
|
179
|
-85.4
|
22.9
|
ROE (net income / shareholders' equity)
|
4.06%
|
2.08%
|
-69.4%
|
2.06%
|
-97.9%
|
-209%
|
ROA (Net income/ Total Assets)
|
1.9%
|
1.22%
|
-10.6%
|
1.15%
|
-3.83%
|
-4.26%
|
Assets
1 |
3,056
|
2,491
|
7,028
|
1,219
|
12,016
|
12,174
|
Book Value Per Share
2 |
6.790
|
6.830
|
3.270
|
3.320
|
1.090
|
0.9500
|
Cash Flow per Share
2 |
1.680
|
0.9800
|
0.3000
|
0.5300
|
0.2600
|
2.130
|
Capex
1 |
186
|
67.8
|
49
|
122
|
12.6
|
57.6
|
Capex / Sales
|
8.47%
|
3.69%
|
2.97%
|
3.68%
|
0.32%
|
1.9%
|
Announcement Date
|
4/25/19
|
4/23/20
|
4/26/21
|
4/27/22
|
4/26/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -32.87% | 314M | | +5.78% | 106B | | -6.47% | 63.94B | | +73.33% | 49.34B | | +17.24% | 39.15B | | +6.13% | 32.86B | | +12.77% | 20.29B | | +15.03% | 17.21B | | +19.06% | 15.28B | | +6.28% | 14.58B |
Other Commodity Chemicals
|